Investigators evaluated the risk for hepatocellular carcinoma after direct-acting antivirals (DAA)-cured hepatitis C virus (HCV) in DAA-naive adults with HIV-HCV coinfection and advanced fibrosis.

Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.

The FDA approved perioperative durvalumab with FLOT chemotherapy for eligible patients with resectable Stage II-IVA gastric and GEJ cancers.

Olezarsen receives FDA Breakthrough Therapy status for adults with severe hypertriglyceridemia following positive results from CORE and CORE2 trials.

Intravenous anesthesia for painless gastroscopy among older adults is associated with lower postoperative cognitive dysfunction.

Incorrect FreeStyle Libre 3 and 3 Plus sensor readings were linked to at least 7 deaths and 700 serious injuries worldwide. The issue affects about 3 million FreeStyle Libre 3 and FreeStyle Libre 3 ...

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

The World Health Organization's new strategic initiative focused on how to harness digital health technologies to improve health.

Children born to mothers with prepregnancy obesity face a higher risk for neurodevelopmental disorders (ie, epilepsy and intellectual disability).

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.